Cidara Therapeutics' IPO

Cidara Therapeutics raised a round of funding on April 15, 2015. Investors include Public.

Cidara, Therapeutics, formerly K2 Therapeutics, is a privately held biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of dise…

Articles about Cidara Therapeutics' IPO: